Health Care Notification Network
New Service Replaces Paper-based Product Safety Alerts With E-mails
By Cindy Borgmeyer
4/23/2008
"It's slow, it's expensive -- often with weeks of delay between the time a notice is required and (when) it actually reaches the physician's hands," Dickey said, referring to the current paper-based notification system. "It's ineffective -- literally stacks of mail come into a physician's office, and it's not uncommon for an alert to be mistaken for marketing and simply tossed away."
Indeed, in a 2006 guidance statement, the FDA specifically addressed the potential benefits of using electronic means to convey voluntary recall communications about FDA-regulated products and important drug safety information, acknowledging the potential pitfalls of using paper notices.
"Many are now concerned that these important drug information communications sent to physicians and other health care providers are not reaching the intended audience in a timely manner or at all," the FDA statement reads. "Letters to health care providers often are screened by one or more 'gatekeepers' and may not reach the intended recipients -- the providers who need the drug information for treating patients."
Mail-based System Heightens Liability Risk
The physician liability issue is key, according to Fotsch, and is the chief driver behind the widespread support the HCNN has achieved among medical liability carriers. To date, more than three dozen medical malpractice carriers have announced their support for the network.
Also signing on to the venture are some 20 health insurers and health care organizations, nearly a dozen medical societies and physician and trade organizations, and various other health care entities.
Janet Woodcock, M.D., acting director of the FDA's Center for Drug Evaluation and Research, saluted the HCNN "for stepping up to the plate and for providing this service."
"FDA fully supports the transition to an interactive, electronic information environment for safety information both for drugs and devices and for biologicals," Woodcock said during the launch event. "We feel this way, doctors and other prescribers, health care professionals, won't be hearing of problems first from the media or from concerned patients who come into their office. So they will not be blind-sided; they will have the emerging information as soon as it's available."
That same timeliness factor is prompting negotiations between the HCNN and the CDC regarding the possibility of using the network to send alerts about national public health emergencies, such as those pertaining to a major infectious disease outbreak or bioterrorism event.
Information Targeted by Specialty
Other benefits of the new service include the clinician's ability to add an office manager or other staff member to the list of designated recipients and a feature that makes it easy for clinicians to send patients appropriate information from HCNN alerts using the clinicians' pre-existing practice e-mail systems.
Recent Decline in U.S. Smoking Prevalence Stalls
USPSTF Revamps Breast Cancer Screening Recommendations
New Report Sounds 'Call to Revolutionize Chronic Pain Care'
AAFP Offers Guidance on FDA Tobacco Regulation
Focus Groups Reveal Physician Concerns About Comparative Effectiveness Research
Manufacturer Recalls Millions of Insulin Syringes
Second Grant to be Used for More Children's Healthy Lifestyles Books
AAFP, Others Reiterate Need for Flu Vaccines in Pregnant Women
Study Suggests Cost for Universal Coverage Misleading
FDA Warns of Adverse Events With Gentamicin Ophthalmic Ointment Use
AAFP, Other Organizations Urge Pregnant Women to Get Flu Vaccines
Physicians Should Recall Children in Need of Hib Booster Dose
FDA Finds Yet More ED Agents Unsafe
'Blue Steel,' 'Hero' Join Long List of Hazardous 'Supplements' for Men
(4/2/2008)
Additional Resource
MedWatch: the FDA Safety Information and Adverse Event Reporting Program








